Role of the cysteine protease cathepsin S in neuropathic hyperalgesia
Role of the cysteine protease cathepsin S in neuropathic hyperalgesia
复制标题
DOI:
10.1016/j.pain.2006.11.017
复制
发表时间:
2007-08-01
期刊:
影响因子:
7.4
通讯作者:
Malcangio, Marzia
中科院分区:
文献类型:
--
作者:
Barclay, Jane;Clark, Anna K.;Malcangio, Marzia
Using a gene expression analysis approach we found that the mRNA encoding the lysosomal cysteine protease cathepsin S (CatS) was up-regulated in rat dorsal root ganglia (DRG) following peripheral nerve injury. CatS protein was expressed in infiltrating macrophages in DRG and near the site of injury. At both sites CatS expression progressively increased from day 3 to day 14 after injury. In naive rats, intraplantar injection of activated rat recombinant (rr) CatS (0.3, 1 mu g/rat) induced a mechanical hyperalgesia that developed within lialf-an-hour, diminished by 3 h and was absent after 24 h. Activated rrCathepsin B (CatB) and non-activated rrCatS injected intraplantarly at the same or higher doses than activated rrCatS had no effect on rat nociceptive thresholds. In nerve-injured rats, mechanical hyperalgesia, but not allodynia, was significantly reversed for up to 3 It by systemic administration of a non-brain penetrant, irreversible CatS inhibitor (LHVS, 3-30 mg/kg s.c.). Depletion of peripheral macrophages by intravenous injection of liposome encapsulate clodronate (1 ml, 5 mg/ml) partially reduced established mechanical hyperalgesia but not allodynia. and abolished the anti-hyperalgesic effect of LHVS. Our results demonstrate a pro-nociceptive effect of CatS and indicate that endogenous CatS released by peripheral macrophages contributes to the maintenance of neuropathic hyperalgesia following nerve injury. (C) 2006 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.